Suppr超能文献

韩国葎草花粉提取物、啤酒花和艾蒿的标准化。

Standardization of Weed Pollen Extracts, Japanese Hop and Mugwort, in Korea.

作者信息

Jeong Kyoung Yong, Son Mina, Choi Soo Young, Park Kyung Hee, Park Hye Jung, Hong Chein Soo, Lee Jae Hyun, Park Jung Won

机构信息

Department of Internal Medicine, Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Yonsei Med J. 2016 Mar;57(2):399-406. doi: 10.3349/ymj.2016.57.2.399.

Abstract

PURPOSE

Japanese hop (Humulus spp.) and mugwort (Artemisia spp.) are notable causes of autumn pollinosis in East Asia. However, Japanese hop and mugwort pollen extracts, which are widely used for the diagnosis, have not been standardized. This study was performed to standardize Japanese hop and mugwort pollen extracts.

MATERIALS AND METHODS

Allergen extracts were prepared in a standardized way using locally collected Humulus japonicus and purchased Artemisia vulgaris pollens. The immunoglobulin E (IgE) reactivities of prepared extracts were compared with commercial extracts via IgE immunoblotting and inhibition analyses. Intradermal skin tests were performed to determine the bioequivalent allergy unit (BAU).

RESULTS

The IgE reactive components of the extracts via IgE immunoblotting were similar to those of commercial extracts. A 11-kDa allergen showed the strongest IgE reactivity in Japanese hop, as did a 28-kDa allergen in mugwort pollen extracts. Allergenic potencies of the investigatory Japanese hop and mugwort extracts were essentially indistinguishable from the commercial ones. Sums of erythema of 50 mm by the intradermal skin test (ΣED50) were calculated to be 14.4th and 13.6th three-fold dilutions for Japanese hop and mugwort extracts, respectively. Therefore, the allergenic activity of the prepared extracts was 90827.4 BAU/mg for Japanese hop and 34412 BAU/mg for mugwort.

CONCLUSION

We produced Japanese hop and mugwort pollen extracts using a standardized method. Standardized Japanese hop and mugwort pollen extracts will facilitate the production of improved diagnostic and immunotherapeutic reagents.

摘要

目的

日本蛇麻草(葎草属)和艾蒿(蒿属)是东亚秋季花粉症的主要病因。然而,广泛用于诊断的日本蛇麻草和艾蒿花粉提取物尚未标准化。本研究旨在对日本蛇麻草和艾蒿花粉提取物进行标准化。

材料与方法

使用当地采集的日本蛇麻草和购买的艾草花粉,以标准化方式制备过敏原提取物。通过IgE免疫印迹和抑制分析,将制备的提取物与商业提取物的免疫球蛋白E(IgE)反应性进行比较。进行皮内皮肤试验以确定生物等效过敏单位(BAU)。

结果

通过IgE免疫印迹法检测,提取物的IgE反应成分与商业提取物相似。一种11 kDa的过敏原在日本蛇麻草中显示出最强的IgE反应性,艾草花粉提取物中的一种28 kDa过敏原也是如此。所研究的日本蛇麻草和艾蒿提取物的致敏效力与商业提取物基本无差异。通过皮内皮肤试验计算出的50 mm红斑总和(ΣED50),日本蛇麻草提取物为第14.4次三倍稀释,艾蒿提取物为第13.6次三倍稀释。因此,制备的提取物的致敏活性对于日本蛇麻草为¬90827.4 BAU/mg,对于艾蒿为34412 BAU/mg。

结论

我们采用标准化方法制备了日本蛇麻草和艾蒿花粉提取物。标准化的日本蛇麻草和艾蒿花粉提取物将有助于生产改进的诊断和免疫治疗试剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4683/4740533/b3df5fe657fa/ymj-57-399-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验